ALTANA Pharma US Selects ASI’s PDRP QuickStart^™ Solution to Achieve Compliance

July 10, 2006--King of Prussia, PA. ASI announces that ALTANA Pharma US, Inc., a subsidiary of the international research-based pharmaceutical company ALTANA Pharma AG, has selected ASI’s PDRP QuickStart^™ solution to address the AMA Prescribing Data Restriction Program (PDRP) that took effect on July 1, 2006.

ASI’s PDRP QuickStart^™ is a comprehensive, enterprise-wide solution designed to help pharmaceutical companies address and implement the technological and procedural requirements necessary to achieve full compliance, in just 30 days. ASI’s proprietary Anti-Reverse Engineering Technology (ART) assures compliance and uses the maximum amount of physician Rx data permitted by the AMA, New Hampshire, and other potential upcoming state legislation.

Jim Alonso, CEO, ASI Business Solutions said, “We are honored to be selected by ALTANA Pharma US to partner in their efforts to achieve full AMA PDRP compliance. ASI is fully committed to helping the pharmaceutical industry with the challenges of AMA PDRP compliance which is why we’ve developed solutions that are compliant, assist in communications and training, does not require dropping records, and provide the maximum flexibility in using current Rx data sources.”